aluates Reports

$ 0.0

Automative

Global Prostacyclin Market Research Report 2026

Published Date: 2026-01-16

Report Code: QYRE-Auto-37Q8793

BUY CHAPTERS

Global Prostacyclin Market Research Report 2026

Code: QYRE-Auto-37Q8793

Report

2026-01-16

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

United Therapeutics

Actelion (J & J)

GSK

TEVA

Toray

Tide Pharma

Bayer

Actelion (J & J)

Dr. Reddy’s Laboratories

Ferrer Internacional

Dompe

Prostacyclin Market Size

The global Prostacyclin market was valued at US$ 1286 million in 2025 and is anticipated to reach US$ 1696 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Prostacyclin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prostacyclin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Prostacyclin (PGI2) is an endogenous prostaglandin derivative secreted by vascular endothelial cells, exhibiting potent vasodilatory and antiplatelet effects. Its primary functions include regulating hemodynamics, inhibiting platelet activation, and improving microcirculation, with wide clinical applications in pulmonary arterial hypertension (PAH), peripheral vascular disorders, and Raynaud’s phenomenon. To enhance stability and extend half-life, synthetic prostacyclin analogues such as Epoprostenol, Treprostinil, and Iloprost have been developed, supporting intravenous, subcutaneous, inhalation, and oral administration routes.In 2024, global Prostacyclin production reached approximately 37.88 m units, with an average global market price of around US$ 32 perunit.The average gross profit margin of this product is 45%.

The global prostacyclin market benefits from the growing population of chronic PAH and peripheral vascular disease patients. Healthcare policies emphasizing early intervention and chronic disease management steadily drive demand for vasodilatory and antiplatelet therapies. Multi-formulation development and home-based administration improve patient adherence and convenience, further expanding market potential. Multinational pharmaceutical companies continue optimizing existing formulations, developing inhaled and oral innovations, and leveraging real-world clinical data to support efficacy and safety, creating new growth drivers. Policy attention to non-opioid pain management and cardiovascular protection also opens additional application opportunities for prostacyclin.

The prostacyclin market faces high cost and complex administration challenges. IV and SC formulations require cold-chain and pump management, increasing clinical and home-use complexity. Some jurisdictions classify prostacyclin as controlled or high-risk, strengthening prescribing and distribution oversight, which limits market expansion. Increasing generic and competitive products intensify price pressure, impacting profitability. Developing novel oral and inhalation formulations demands significant investment in process optimization and clinical validation, while half-life and stability remain critical formulation challenges.

Downstream demand is diversifying and shifting toward chronic disease management. Beyond traditional PAH indications, inhaled and oral formulations are increasingly used in peripheral vascular disorders, Raynaud’s phenomenon, and microcirculation impairments, promoting long-term home use. Focus on formulation innovation, adherence, and quality-of-life improvements drives extended-release, combination, and smart-pump products. The rise of e-prescription and telemedicine channels enables patients to access prostacyclin therapy more conveniently, creating an integrated online-offline market.

Production of prostacyclin and its analogues depends on high-purity organic intermediates and fine chemicals, requiring sensitive, complex processes. Upstream supply is highly concentrated, with China and India offering scale and cost advantages but facing exposure to environmental regulation, trade policies, and raw material price volatility. Leading companies mitigate risk through multi-source procurement, long-term supply agreements, and green chemistry process improvements, while employing automation and strict quality control to ensure product stability and batch consistency. Upstream stability and accessibility directly affect downstream formulation cost, delivery efficiency, and market competitiveness.

This report delivers a comprehensive overview of the global Prostacyclin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostacyclin. The Prostacyclin market size, estimates, and forecasts are provided in terms of sales volume (K Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Prostacyclin market comprehensively. Regional market sizes by Type, by Application, by Chemical Structure, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Prostacyclin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Prostacyclin Market Report

Report Metric	Details
Report Name	Prostacyclin Market
Accounted market size in 2025	US$ 1286 million
Forecasted market size in 2032	US$ 1696 million
CAGR	4.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Epoprostenol Sodium Treprostinil Iloprost Beraprost Sodium
Segment by Chemical Structure	Endogenous Prostacyclin Synthetic Prostacyclin Analogues
Segment by Route of Administration	Intravenous Subcutaneous Inhaled Oral
by Application	Hospital Retail Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG, Ferrer Internacional, Dompe, Dr Reddy's Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Chemical Structure, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prostacyclin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Prostacyclin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Prostacyclin Market growing?

Ans: The Prostacyclin Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Prostacyclin Market size in 2032?

Ans: The Prostacyclin Market size in 2032 will be US$ 1696 million.

Who are the main players in the Prostacyclin Market report?

Ans: The main players in the Prostacyclin Market are United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG, Ferrer Internacional, Dompe, Dr Reddy's Laboratories

What are the Application segmentation covered in the Prostacyclin Market report?

Ans: The Applications covered in the Prostacyclin Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Prostacyclin Market report?

Ans: The Types covered in the Prostacyclin Market report are Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium

1 Prostacyclin Market Overview

1.1 Product Definition

1.2 Prostacyclin by Type

1.2.1 Global Prostacyclin Market Value by Type: 2025 vs 2032

1.2.2 Epoprostenol Sodium

1.2.3 Treprostinil

1.2.4 Iloprost

1.2.5 Beraprost Sodium

1.3 Prostacyclin by Chemical Structure

1.3.1 Global Prostacyclin Market Value by Chemical Structure: 2025 vs 2032

1.3.2 Endogenous Prostacyclin

1.3.3 Synthetic Prostacyclin Analogues

1.4 Prostacyclin by Route of Administration

1.4.1 Global Prostacyclin Market Value by Route of Administration: 2025 vs 2032

1.4.2 Intravenous

1.4.3 Subcutaneous

1.4.4 Inhaled

1.4.5 Oral

1.5 Prostacyclin by Application

1.5.1 Global Prostacyclin Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Retail Pharmacy

1.5.4 Other

1.6 Global Prostacyclin Market Size Estimates and Forecasts

1.6.1 Global Prostacyclin Revenue 2021–2032

1.6.2 Global Prostacyclin Sales 2021–2032

1.6.3 Global Prostacyclin Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Prostacyclin Market Competition by Manufacturers

2.1 Global Prostacyclin Sales Market Share by Manufacturers (2021–2026)

2.2 Global Prostacyclin Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Prostacyclin Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Prostacyclin, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Prostacyclin, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Prostacyclin, Product Types and Applications

2.7 Global Key Manufacturers of Prostacyclin, Date of Entry into the Industry

2.8 Global Prostacyclin Market Competitive Situation and Trends

2.8.1 Global Prostacyclin Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Prostacyclin Players Market Share by Revenue

2.8.3 Global Prostacyclin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Prostacyclin Market Scenario by Region

3.1 Global Prostacyclin Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Prostacyclin Sales by Region: 2021–2032

3.2.1 Global Prostacyclin Sales by Region: 2021–2026

3.2.2 Global Prostacyclin Sales by Region: 2027–2032

3.3 Global Prostacyclin Revenue by Region: 2021–2032

3.3.1 Global Prostacyclin Revenue by Region: 2021–2026

3.3.2 Global Prostacyclin Revenue by Region: 2027–2032

3.4 North America Prostacyclin Market Facts & Figures by Country

3.4.1 North America Prostacyclin Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Prostacyclin Sales by Country (2021–2032)

3.4.3 North America Prostacyclin Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Prostacyclin Market Facts & Figures by Country

3.5.1 Europe Prostacyclin Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Prostacyclin Sales by Country (2021–2032)

3.5.3 Europe Prostacyclin Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prostacyclin Market Facts & Figures by Region

3.6.1 Asia Pacific Prostacyclin Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Prostacyclin Sales by Region (2021–2032)

3.6.3 Asia Pacific Prostacyclin Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Prostacyclin Market Facts & Figures by Country

3.7.1 Latin America Prostacyclin Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Prostacyclin Sales by Country (2021–2032)

3.7.3 Latin America Prostacyclin Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prostacyclin Market Facts & Figures by Country

3.8.1 Middle East and Africa Prostacyclin Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Prostacyclin Sales by Country (2021–2032)

3.8.3 Middle East and Africa Prostacyclin Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Prostacyclin Sales by Type (2021–2032)

4.1.1 Global Prostacyclin Sales by Type (2021–2026)

4.1.2 Global Prostacyclin Sales by Type (2027–2032)

4.1.3 Global Prostacyclin Sales Market Share by Type (2021–2032)

4.2 Global Prostacyclin Revenue by Type (2021–2032)

4.2.1 Global Prostacyclin Revenue by Type (2021–2026)

4.2.2 Global Prostacyclin Revenue by Type (2027–2032)

4.2.3 Global Prostacyclin Revenue Market Share by Type (2021–2032)

4.3 Global Prostacyclin Price by Type (2021–2032)

5 Segment by Application

5.1 Global Prostacyclin Sales by Application (2021–2032)

5.1.1 Global Prostacyclin Sales by Application (2021–2026)

5.1.2 Global Prostacyclin Sales by Application (2027–2032)

5.1.3 Global Prostacyclin Sales Market Share by Application (2021–2032)

5.2 Global Prostacyclin Revenue by Application (2021–2032)

5.2.1 Global Prostacyclin Revenue by Application (2021–2026)

5.2.2 Global Prostacyclin Revenue by Application (2027–2032)

5.2.3 Global Prostacyclin Revenue Market Share by Application (2021–2032)

5.3 Global Prostacyclin Price by Application (2021–2032)

6 Key Companies Profiled

6.1 United Therapeutics

6.1.1 United Therapeutics Company Information

6.1.2 United Therapeutics Description and Business Overview

6.1.3 United Therapeutics Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 United Therapeutics Prostacyclin Product Portfolio

6.1.5 United Therapeutics Recent Developments/Updates

6.2 Actelion (J & J)

6.2.1 Actelion (J & J) Company Information

6.2.2 Actelion (J & J) Description and Business Overview

6.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Actelion (J & J) Prostacyclin Product Portfolio

6.2.5 Actelion (J & J) Recent Developments/Updates

6.3 GSK

6.3.1 GSK Company Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 GSK Prostacyclin Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Teva

6.4.1 Teva Company Information

6.4.2 Teva Description and Business Overview

6.4.3 Teva Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Teva Prostacyclin Product Portfolio

6.4.5 Teva Recent Developments/Updates

6.5 Toray

6.5.1 Toray Company Information

6.5.2 Toray Description and Business Overview

6.5.3 Toray Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Toray Prostacyclin Product Portfolio

6.5.5 Toray Recent Developments/Updates

6.6 Tide Pharma

6.6.1 Tide Pharma Company Information

6.6.2 Tide Pharma Description and Business Overview

6.6.3 Tide Pharma Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Tide Pharma Prostacyclin Product Portfolio

6.6.5 Tide Pharma Recent Developments/Updates

6.7 Bayer AG

6.7.1 Bayer AG Company Information

6.7.2 Bayer AG Description and Business Overview

6.7.3 Bayer AG Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Bayer AG Prostacyclin Product Portfolio

6.7.5 Bayer AG Recent Developments/Updates

6.8 Ferrer Internacional

6.8.1 Ferrer Internacional Company Information

6.8.2 Ferrer Internacional Description and Business Overview

6.8.3 Ferrer Internacional Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Ferrer Internacional Prostacyclin Product Portfolio

6.8.5 Ferrer Internacional Recent Developments/Updates

6.9 Dompe

6.9.1 Dompe Company Information

6.9.2 Dompe Description and Business Overview

6.9.3 Dompe Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Dompe Prostacyclin Product Portfolio

6.9.5 Dompe Recent Developments/Updates

6.10 Dr Reddy's Laboratories

6.10.1 Dr Reddy's Laboratories Company Information

6.10.2 Dr Reddy's Laboratories Description and Business Overview

6.10.3 Dr Reddy's Laboratories Prostacyclin Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Dr Reddy's Laboratories Prostacyclin Product Portfolio

6.10.5 Dr Reddy's Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Prostacyclin Industry Chain Analysis

7.2 Prostacyclin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prostacyclin Production Mode & Process Analysis

7.4 Prostacyclin Sales and Marketing

7.4.1 Prostacyclin Sales Channels

7.4.2 Prostacyclin Distributors

7.5 Prostacyclin Customer Analysis

8 Prostacyclin Market Dynamics

8.1 Prostacyclin Industry Trends

8.2 Prostacyclin Market Drivers

8.3 Prostacyclin Market Challenges

8.4 Prostacyclin Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

United Therapeutics

Actelion (J & J)

GSK

TEVA

Toray

Tide Pharma

Bayer

Actelion (J & J)

Dr. Reddy’s Laboratories

Ferrer Internacional

Dompe

List of Tables

Table 1. Global Prostacyclin Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Prostacyclin Market Value by Chemical Structure (US$ Million), 2025 vs 2032

Table 3. Global Prostacyclin Market Value by Route of Administration (US$ Million), 2025 vs 2032

Table 4. Global Prostacyclin Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Prostacyclin Market Competitive Situation by Manufacturers in 2025

Table 6. Global Prostacyclin Sales (K Unit) of Key Manufacturers (2021–2026)

Table 7. Global Prostacyclin Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Prostacyclin Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Prostacyclin Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Prostacyclin Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Prostacyclin, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Prostacyclin, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Prostacyclin, Product Types and Applications

Table 14. Global Key Manufacturers of Prostacyclin, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Prostacyclin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prostacyclin Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Prostacyclin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Prostacyclin Sales by Region (K Unit), 2021–2026

Table 20. Global Prostacyclin Sales Market Share by Region (2021–2026)

Table 21. Global Prostacyclin Sales by Region (K Unit), 2027–2032

Table 22. Global Prostacyclin Sales Market Share by Region (2027–2032)

Table 23. Global Prostacyclin Revenue by Region (US$ Million), 2021–2026

Table 24. Global Prostacyclin Revenue Market Share by Region (2021–2026)

Table 25. Global Prostacyclin Revenue by Region (US$ Million), 2027–2032

Table 26. Global Prostacyclin Revenue Market Share by Region (2027–2032)

Table 27. North America Prostacyclin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Prostacyclin Sales by Country (K Unit), 2021–2026

Table 29. North America Prostacyclin Sales by Country (K Unit), 2027–2032

Table 30. North America Prostacyclin Revenue by Country (US$ Million), 2021–2026

Table 31. North America Prostacyclin Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Prostacyclin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Prostacyclin Sales by Country (K Unit), 2021–2026

Table 34. Europe Prostacyclin Sales by Country (K Unit), 2027–2032

Table 35. Europe Prostacyclin Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Prostacyclin Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Prostacyclin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Prostacyclin Sales by Region (K Unit), 2021–2026

Table 39. Asia Pacific Prostacyclin Sales by Region (K Unit), 2027–2032

Table 40. Asia Pacific Prostacyclin Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Prostacyclin Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Prostacyclin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Prostacyclin Sales by Country (K Unit), 2021–2026

Table 44. Latin America Prostacyclin Sales by Country (K Unit), 2027–2032

Table 45. Latin America Prostacyclin Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Prostacyclin Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Prostacyclin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Prostacyclin Sales by Country (K Unit), 2021–2026

Table 49. Middle East and Africa Prostacyclin Sales by Country (K Unit), 2027–2032

Table 50. Middle East and Africa Prostacyclin Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Prostacyclin Revenue by Country (US$ Million), 2027–2032

Table 52. Global Prostacyclin Sales (K Unit) by Type (2021–2026)

Table 53. Global Prostacyclin Sales (K Unit) by Type (2027–2032)

Table 54. Global Prostacyclin Sales Market Share by Type (2021–2026)

Table 55. Global Prostacyclin Sales Market Share by Type (2027–2032)

Table 56. Global Prostacyclin Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Prostacyclin Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Prostacyclin Revenue Market Share by Type (2021–2026)

Table 59. Global Prostacyclin Revenue Market Share by Type (2027–2032)

Table 60. Global Prostacyclin Price (USD/Unit) by Type (2021–2026)

Table 61. Global Prostacyclin Price (USD/Unit) by Type (2027–2032)

Table 62. Global Prostacyclin Sales (K Unit) by Application (2021–2026)

Table 63. Global Prostacyclin Sales (K Unit) by Application (2027–2032)

Table 64. Global Prostacyclin Sales Market Share by Application (2021–2026)

Table 65. Global Prostacyclin Sales Market Share by Application (2027–2032)

Table 66. Global Prostacyclin Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Prostacyclin Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Prostacyclin Revenue Market Share by Application (2021–2026)

Table 69. Global Prostacyclin Revenue Market Share by Application (2027–2032)

Table 70. Global Prostacyclin Price (USD/Unit) by Application (2021–2026)

Table 71. Global Prostacyclin Price (USD/Unit) by Application (2027–2032)

Table 72. United Therapeutics Company Information

Table 73. United Therapeutics Description and Business Overview

Table 74. United Therapeutics Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 75. United Therapeutics Prostacyclin Product

Table 76. United Therapeutics Recent Developments/Updates

Table 77. Actelion (J & J) Company Information

Table 78. Actelion (J & J) Description and Business Overview

Table 79. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 80. Actelion (J & J) Prostacyclin Product

Table 81. Actelion (J & J) Recent Developments/Updates

Table 82. GSK Company Information

Table 83. GSK Description and Business Overview

Table 84. GSK Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 85. GSK Prostacyclin Product

Table 86. GSK Recent Developments/Updates

Table 87. Teva Company Information

Table 88. Teva Description and Business Overview

Table 89. Teva Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 90. Teva Prostacyclin Product

Table 91. Teva Recent Developments/Updates

Table 92. Toray Company Information

Table 93. Toray Description and Business Overview

Table 94. Toray Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 95. Toray Prostacyclin Product

Table 96. Toray Recent Developments/Updates

Table 97. Tide Pharma Company Information

Table 98. Tide Pharma Description and Business Overview

Table 99. Tide Pharma Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 100. Tide Pharma Prostacyclin Product

Table 101. Tide Pharma Recent Developments/Updates

Table 102. Bayer AG Company Information

Table 103. Bayer AG Description and Business Overview

Table 104. Bayer AG Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 105. Bayer AG Prostacyclin Product

Table 106. Bayer AG Recent Developments/Updates

Table 107. Ferrer Internacional Company Information

Table 108. Ferrer Internacional Description and Business Overview

Table 109. Ferrer Internacional Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 110. Ferrer Internacional Prostacyclin Product

Table 111. Ferrer Internacional Recent Developments/Updates

Table 112. Dompe Company Information

Table 113. Dompe Description and Business Overview

Table 114. Dompe Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 115. Dompe Prostacyclin Product

Table 116. Dompe Recent Developments/Updates

Table 117. Dr Reddy's Laboratories Company Information

Table 118. Dr Reddy's Laboratories Description and Business Overview

Table 119. Dr Reddy's Laboratories Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 120. Dr Reddy's Laboratories Prostacyclin Product

Table 121. Dr Reddy's Laboratories Recent Developments/Updates

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Prostacyclin Distributors List

Table 125. Prostacyclin Customers List

Table 126. Prostacyclin Market Trends

Table 127. Prostacyclin Market Drivers

Table 128. Prostacyclin Market Challenges

Table 129. Prostacyclin Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. Product Picture of Prostacyclin

Figure 2. Global Prostacyclin Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Prostacyclin Market Share by Type: 2025 & 2032

Figure 4. Epoprostenol Sodium Product Picture

Figure 5. Treprostinil Product Picture

Figure 6. Iloprost Product Picture

Figure 7. Beraprost Sodium Product Picture

Figure 8. Global Prostacyclin Market Value by Chemical Structure (US$ Million), 2021–2032

Figure 9. Global Prostacyclin Market Share by Chemical Structure: 2025 vs 2032

Figure 10. Endogenous Prostacyclin Product Picture

Figure 11. Synthetic Prostacyclin Analogues Product Picture

Figure 12. Global Prostacyclin Market Value by Route of Administration (US$ Million), 2021–2032

Figure 13. Global Prostacyclin Market Share by Route of Administration: 2025 vs 2032

Figure 14. Intravenous Product Picture

Figure 15. Subcutaneous Product Picture

Figure 16. Inhaled Product Picture

Figure 17. Oral Product Picture

Figure 18. Global Prostacyclin Market Value by Application (US$ Million), 2021–2032

Figure 19. Global Prostacyclin Market Share by Application: 2025 & 2032

Figure 20. Hospital

Figure 21. Retail Pharmacy

Figure 22. Other

Figure 23. Global Prostacyclin Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Prostacyclin Market Size (US$ Million), 2021–2032

Figure 25. Global Prostacyclin Sales (K Unit), 2021–2032

Figure 26. Global Prostacyclin Average Price (USD/Unit), 2021–2032

Figure 27. Prostacyclin Report Years Considered

Figure 28. Prostacyclin Sales Share by Manufacturers in 2025

Figure 29. Global Prostacyclin Revenue Share by Manufacturers in 2025

Figure 30. Top 5 and Top 10 Global Prostacyclin Players: Market Share by Revenue in Prostacyclin in 2025

Figure 31. Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 32. Global Prostacyclin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 33. North America Prostacyclin Sales Market Share by Country (2021–2032)

Figure 34. North America Prostacyclin Revenue Market Share by Country (2021–2032)

Figure 35. U.S. Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Canada Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Europe Prostacyclin Sales Market Share by Country (2021–2032)

Figure 38. Europe Prostacyclin Revenue Market Share by Country (2021–2032)

Figure 39. Germany Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. France Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. U.K. Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Italy Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Russia Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Asia Pacific Prostacyclin Sales Market Share by Region (2021–2032)

Figure 45. Asia Pacific Prostacyclin Revenue Market Share by Region (2021–2032)

Figure 46. China Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Japan Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. South Korea Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. India Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Australia Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. China Taiwan Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Indonesia Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Thailand Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Malaysia Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Philippines Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Latin America Prostacyclin Sales Market Share by Country (2021–2032)

Figure 57. Latin America Prostacyclin Revenue Market Share by Country (2021–2032)

Figure 58. Mexico Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Brazil Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Argentina Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Middle East and Africa Prostacyclin Sales Market Share by Country (2021–2032)

Figure 62. Middle East and Africa Prostacyclin Revenue Market Share by Country (2021–2032)

Figure 63. Turkey Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Saudi Arabia Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. U.A.E Prostacyclin Revenue Growth Rate (US$ Million), 2021–2032

Figure 66. Global Sales Market Share of Prostacyclin by Type (2021–2032)

Figure 67. Global Revenue Market Share of Prostacyclin by Type (2021–2032)

Figure 68. Global Prostacyclin Price (USD/Unit) by Type (2021–2032)

Figure 69. Global Sales Market Share of Prostacyclin by Application (2021–2032)

Figure 70. Global Revenue Market Share of Prostacyclin by Application (2021–2032)

Figure 71. Global Prostacyclin Price (USD/Unit) by Application (2021–2032)

Figure 72. Prostacyclin Value Chain

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Prostaglandins and Related Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostacyclin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostaglandin I2 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Indometacin Indomethacin Market Research Report 2024

Global Indomethacin Tablets Market Research Report 2024

Global Arachidonic Acid Market Research Report 2024

Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024

Global Cyclooxygenase 2 Inhibitor Market Research Report 2024

Global Specific COX 2 Inhibitors Market Research Report 2024

Global Pets NSAIDs Market Research Report 2025

Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024

Global Indomethacin Market Research Report 2024

Global Indometacin Patches Market Research Report 2024

Global PG Hormone Market Research Report 2025

Global Prostaglandin endoperoxide Synthase 2 COX 2 Protein Market Research Report 2024

Global Anti inflammatory Agents Market Research Report 2024

Non Steroidal Anti Inflammatory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030

Global Prostaglandin endoperoxide Synthase 2 COX 2 Antibody Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions